Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers.

Abstract Background Genomic analysis is essential for risk stratification in patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). Whole-genome sequencing is a potential re...